Online Mindfulness-based Stress Reduction for Patients Receiving Chemotherapy

NCT06534957 | Completed

• 1 other identifier: ECA-MIND-QT
• Study Type: interventional
• Target: 128
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this prospective, waitlist-controlled, 1:1 randomized study is to evaluate if an online mindfulness-based intervention (MBI) reduces treatment-related stress levels among patients with breast cancer receiving chemotherapy. The main questions it aims to answer are:

• Does an online MBI intervention reduce stress levels (measured through the Perceived Stress Scale) among participants?
• Does an online MBI intervention reduce anxiety, depression, insomnia, fatigue, nausea, diarrhea, constipation, pain, and peripheral neuropathy (measured through the PRO-CTCAE of the National Cancer Institute) among participants? Researchers will compare the online MBI to no intervention to see if online MBI reduces treatment-related stress. Participants will:
• Participate in an online MBI or no intervention for 6 weeks
• Answer the study surveys at baseline, 7 weeks, and 11 weeks of follow-up

Conditions

Breast Cancer; Stress

Keywords

breast cancer; mindfulness-based intervention; mindfulness; online mindfulness; chemotherapy-related stress; treatment-related stress

Outcome Measures

Primary Outcomes (1)

• Stress

  Measured through the Perceived Stress Scale (PSS). The PSS is a self-report instrument that assesses the level of perceived stress over the past month. It consists of 10 items that are rated using a 5-point Likert scale (0: Never; 1: Almost never; 2: Sometimes; 3: Fairly often; 4: Very often). The total score is obtained by adding the scores of the 10 items, obtaining a total value between 0-40, where higher scores indicate a higher level of perceived stress. A moderate stress level is considered between 14-26 points, and a high stress level is considered when obtaining \>27 points.

  11 weeks

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will be assessed with the study surveys at baseline (T1), will participate in the online MBI for the next 6 weeks, and will be subsequently reassessed with the study surveys at 7 weeks (T2) and at 11 weeks (T3) of follow-up.

Other: Online mindfulness-based stress reduction

Wait-list control group

NO INTERVENTION

A wait-list control group will be used with the objective that all participants have the opportunity of receiving the online MBI and at the same time allow comparison of the effectiveness of the program with a group without intervention. Given that treatment-related stress has an important negative impact on patients' wellbeing, it is appropriate to offer the control group the possibility of receiving the intervention if its effectiveness is demonstrated. The control group will be assessed with the study surveys at baseline (T1), will not participate in the online MBI for the next 6 weeks, and will be subsequently reassessed with the study surveys at the same timepoints as the intervention group at 7 weeks (T2) and at 11 weeks (T3) of follow-up. Upon completion of recruitment and follow-up of all participants, the study will end, and the control group will be able to receive the online MBI according to their preference.

Interventions

Online mindfulness-based stress reduction OTHER

The online MBI sessions will be available in a website created specifically for this purpose, where each pre-recorded session will be uploaded so that each patient can begin the intervention at the same time as their chemotherapy regimen. Each session will last approximately 1 hour, for a total of 6 sessions. The topics that will be covered in these sessions include: mindfulness overview, stress and suffering, emotional regulation, meditation, management of stressful situations, self-compassion and acceptance. Participants will watch 1 session per week following the order that will be indicated on the website; patients will be encouraged to watch the sessions during their chemotherapy infusions. During these sessions, patients will be instructed in mindfulness practice and will perform targeted exercises to promote complete consciousness, including mindful body awareness (body scan) and meditation.

Intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Female sex
• Age ≥18 years
• Diagnosis of non-metastatic breast cancer
• Treatment with neoadjuvant or adjuvant chemotherapy or plan to start chemotherapy in \<4 weeks
• Internet access at home or in their mobile phone
• Availability to participate in the online MBI for 6 weeks
• Availability to answer the study surveys
• Provision of signed informed consent

You may not qualify if:

• Disease recurrence
• Current meditation or mindfulness practice
• Inability to read or write

Sponsors & Collaborators

• Medicos e Investigadores en la Lucha contra el Cancer de Mama: lead

Study Sites (1)

Hospital Zambrano Hellion

San Pedro Garza García, Nuevo León, 66278, Mexico

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Masking Details: Given the nature of the intervention, the study will be open and participants will know which group they were randomized to. However, the study will be blinded to the statistician in order to reduce the risk of introducing bias when interpreting the data.
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 30, 2024
• First Posted: August 2, 2024
• Study Start: September 2, 2025
• Primary Completion: June 1, 2026
• Study Completion: June 1, 2026
• Last Updated: June 29, 2026

Record last verified: 2026-06

Locations

ME (1)